In Loving Memory of Florence Duvieusart
1 August 2024
Efficiency in cancer care
All.Can is committed to efficiency in cancer care. By working with all stakeholders, we aim to achieve our goal: better health outcomes for cancer patients. This is why we focus on finding, supporting and sharing evidence-based and measurable ways to improve cancer care.
Working together for efficient cancer care
All.Can Belgium is committed to efficiency in cancer care. But what exactly does that mean?
The All.Can Cancer Efficiency Metrics Study (2022) provides an answer to this question. Eight key metrics emerge from this comprehensive international study. These metrics can be used to assess and improve efficiency in cancer care.
- 1 Time to diagnosis
- 2 Percentage of cancers diagnosed through emergency presentation
- 3 Primary care interval
- 4 Time from tissue diagnosis to treatment
- 5 Percentage of patients documented as having seen a Clinical Nurse Specialist (CNS)
- 6 Percentage of patients who received chemotherapy in the last 14 days of life
- 7 Patient experience
- 8 Patient involvement in decision-making
Working together for efficient cancer care
All.Can Belgium is committed to efficiency in cancer care. But what exactly does that mean?
The All.Can Cancer Efficiency Metrics Study (2022) provides an answer to this question. Eight key metrics emerge from this comprehensive international study. These metrics can be used to assess and improve efficiency in cancer care.
- 1 Time to diagnosis
- 2 Percentage of cancers diagnosed through emergency presentation
- 3 Primary care interval
- 4 Time from tissue diagnosis to treatment
- 5 Percentage of patients documented as having seen a Clinical Nurse Specialist (CNS)
- 6 Percentage of patients who received chemotherapy in the last 14 days of life
- 7 Patient experience
- 8 Patient involvement in decision-making
All.Can Belgium uses these eight parameters to set up and evaluate projects. For example, our ‘Get Checked Early’ campaign emphasises the importance of timely diagnosis and therefore ties in with the first parameter (time to diagnosis).
News
In Loving Memory of Florence Duvieusart
1 August 2024
Sarcomas are tumours of the bone or soft tissues of the body. Because they are so rare, a lot of healthcare providers fail to recognize the red flags. Prof. Dr. Gwen Sys (Ghent University Hospital) summarizes their main features for her fellow physicians.
Sarcoma patient Eva’s treatment process left much to be desired. The tumor was not identified as malignant until late in the diagnostic process, resulting in a lot of lost time. That's why Eva wants to share her story with others. "I hope other people can learn from it."
When you are diagnosed with cancer, you are faced with 1,001 challenges: not only health-related, but also emotional, social, professional, and economic. As an oncology nurse coordinator, Sylvie Lambin answers her patients' questions and concerns from a professional perspective.
As the elections are approaching, we talked to Professor Dr. Ahmad Awada, Chair of our Board. What is his message for policymakers? "It's impossible to address all cancer care needs simultaneously, which means it's extremely important to focus on efficiency."
In Loving Memory of David Gaier
30 April 2024
Exciting news: Welcome Professor Dr Paul Van Schil!
24 February 2024
